TECHNETIUM TC 99M HEXAMETHYL PROPYLENE AMINE OXINE LEUKOCYTE SCINTIGRAPHY IN PATIENTS WITH ULCERATIVE-COLITIS - CORRELATION WITH CLINICAL, BIOLOGIC, ENDOSCOPIC, AND PATHOLOGICAL INTENSITY, AND LOCAL RELEASE OFINTERLEUKIN-8
R. Guimbaud et al., TECHNETIUM TC 99M HEXAMETHYL PROPYLENE AMINE OXINE LEUKOCYTE SCINTIGRAPHY IN PATIENTS WITH ULCERATIVE-COLITIS - CORRELATION WITH CLINICAL, BIOLOGIC, ENDOSCOPIC, AND PATHOLOGICAL INTENSITY, AND LOCAL RELEASE OFINTERLEUKIN-8, Gastrointestinal endoscopy, 48(5), 1998, pp. 491-496
Background: Technetium Tc 99m hexamethyl propylene amine oxine (Tc-99m
-HMPAO) has been used to radiolabel leukocytes with promising results
for its clinical use in inflammatory bowel disease. During active ulce
rative colitis, colonoscopy is indicated to determine the extent and t
he intensity of the disease for proper management. The aim of this pro
spective study was to determine whether Tc-99m-HMPAO-labeled leukocyte
scintigraphy can give information similar to that obtained with colon
oscopy during acute attacks of ulcerative colitis. Methods: Thirty-thr
ee consecutive patients with 50 acute episodes of ulcerative colitis u
nderwent Tc-99m-HMPAO scintigraphy and colonoscopy with biopsies. Scin
tigraphic determination of disease extent and intensity were compared
with those obtained by colonoscopy with biopsies and clinico-biologic
markers. Results: The scintigraphic index of disease intensity was cor
related with endoscopic index, Truelove index, biologic markers, and l
ocal release of interleukin-8. The extent measured by scintigraphy was
well correlated to the endoscopic and histologic extent. Conclusions:
Tc-99m-HMPAO scintigraphy accurately determines the extent and the in
tensity of acute ulcerative colitis lesions. This noninvasive method c
an specify the extent and the intensity of an acute attack in patients
with previously known ulcerative colitis.